Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
MUMBAI: India’s Sun Pharmaceutical Industries fell short of its targeted debt fundraise as investors continued to demand higher yields, three merchant bankers said on Thursday. The country’s largest drugmaker by market capitalization raised only 78.16 billion rupees ($823.65 million) through the sale of two sets of over five-year bonds, comfortably lower than target of 100 billion rupees, the…
We haven't written up this one. Business Recorder has the full story — the link below goes straight to it.
